Castle Biosciences (CSTL) Non-Current Deffered Revenue (2018 - 2021)
Castle Biosciences (CSTL) posted Non-Current Deffered Revenue of $986000.0 for Q3 2021, up 2.39% sequentially from $963000.0 in Q2 2021, and down 13.51% YoY from $1.1 million in Q3 2020.
Castle Biosciences (CSTL) Non-Current Deffered Revenue (2018 - 2021) Analysis & Trends
Castle Biosciences has reported Non-Current Deffered Revenue for 4 years, with the latest figure at $986000.0 in Q3 2021.
- Quarterly Non-Current Deffered Revenue fell 13.51% year-over-year to $986000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $986000.0 (down 13.51% YoY) and the FY2020 annual result came in at $1.7 million, up 3054.55% from the prior year.
- Non-Current Deffered Revenue improved to $986000.0 in Q3 2021 per CSTL's latest filing, from $963000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $1.7 million in Q4 2020 and troughed at $44000.0 in Q4 2018.
- A 4-year average of $638699.6 and a median of $941000.0 in 2020 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2020 and 2021: Non-Current Deffered Revenue surged 3054.55% in 2020, then declined 13.51% in 2021.
- Over 4 years, Non-Current Deffered Revenue stood at $44000.0 in 2018, then climbed by 25.0% to $55000.0 in 2019, then soared by 3054.55% to $1.7 million in 2020, then slumped by 43.17% to $986000.0 in 2021.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $986000.0, $963000.0, and $995000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 16.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 32.59 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 986,000.00 |
| Jun 30, 2021 | 963,000.00 |
| Mar 31, 2021 | 995,000.00 |
| Dec 31, 2020 | 1.74 Mn |
| Sep 30, 2020 | 1.14 Mn |
| Jun 30, 2020 | 941,000.00 |
| Mar 31, 2020 | 54,000.00 |
| Dec 31, 2019 | 55,000.00 |
| Sep 30, 2019 | 56,006.00 |
| Jun 30, 2019 | 56,690.00 |
| Dec 31, 2018 | 44,000.00 |